academic article

• Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes..  Clinical cancer research : an official journal of the American Association for Cancer Research.  23:3794-3801. 2017
• Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers..  The American journal of surgical pathology.  :-. 2015